Start-up
Hybridize Therapeutics
About Hybridize Therapeutics
Hybridize Therapeutics is a spin-off from the Department of Nephrology at the Leiden University Medical Center (LUMC). The LUMC has played pioneering role in both nephrology (kidney dialysis) and RNA-based medicine (oligonucleotide chemistry and synthesis). Hybridize has merged these areas in its mission, focusing on helping patients overcome untreated kidney diseases with high unmet medical needs using RNA-based therapeutics. Next to its program on BK-virus, Hybridize has a pipeline of programs ongoing leveraging a similar RNA-based strategy as applied for the BKV programs. The program areas include undisclosed molecules targeting kidney monogenic diseases and anti-inflammation/fibrosis.
- Founding: 2019
- Focus : Manufacturer
- Industry : Biotechnology, Pharma
Advertisement
News about Hybridize Therapeutics
Here you will find Hybridize Therapeutics
Last viewed contents
SOLID Therapeutics - Copenhagen, Denmark
Genicity - Newcastle, Galway, United Kingdom
Heqet Therapeutics - Torino, Italy
Merck Life Science KGaA - Darmstadt, Germany
StratifAI Raises €12.5M for Clinical Validation of AI Biomarker Platform for Precision Oncology - Oversubscribed round expand global reach, and unlock multi‑billion‑euro cancer diagnostics market
Simply taste your way to flu infection - Rapid test for influenza viruses using chewing gum – without the need for a laboratory, electricity or medical personnel
Transparent artificial intelligence improves assessment of prostate cancer aggressiveness - AI speaks the language of pathologists
New nanosensors make diagnostic procedures more sensitive - The nanosensors can be used to track reactions with invisible light, saving materials and time
Cyber Valley grants 500K to CELL’n’ROLL via 2023 Innovation Fellowship Program - Cyber Valley Community is advancing diagnostics for the future: Its goal is to create an innovative spin-off from the project after the funding term has ended
Blood diagnostics modelled on leeches - For all those who are afraid of needles: New device for taking blood samples uses microneedles and a suction cup instead of a large needle
AI personalises brain tumour therapy - Progress in the personalised treatment of brain tumours: AI identifies mutations
